Goldman Sachs Group Inc P Lx Pharma Inc. Transaction History

Goldman Sachs Group Inc

  • $555 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

May 14, 2024
BUY
$0.15 - $0.63 $1,893 - $7,950
12,620 New
12,620 $2,000
Q4 2022

Feb 13, 2023
BUY
$0.15 - $0.63 $1,893 - $7,950
12,620 New
12,620 $2,000
Q1 2022

May 16, 2022
SELL
$3.54 - $8.3 $112,579 - $263,956
-31,802 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$7.69 - $19.66 $244,557 - $625,227
31,802 New
31,802 $255,000

Others Institutions Holding PLXP

# of Institutions
4
Shares Held
61.6K
Call Options Held
0
Put Options Held
0
View Full List

About PLx Pharma Inc.

PLXP Quotes by TradingView
  • Ticker PLXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,137,700
  • Description
  • PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...
More about PLXP
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email